SEC Form 4 reporting owner

Taylor Ben R

Taylor Ben R has filed 13 Form 4 transactions reported between December 29, 2025 and September 15, 2026, as Chief Financial Officer of RECURSION PHARMACEUTICALS, INC..

Name as filed: Taylor Ben R

Open-market buys, 24 mo

None

reported

Open-market sales, 24 mo

$158K

3 lines

Companies

with Form 4 filings

Latest transaction

Sep 15, 2026

transaction date

Roles and reported holdings

RXRXRECURSION PHARMACEUTICALS, INC.
Dec 29, 2025 – Sep 15, 2026
Chief Financial Officer
Held directly1,071,462 sh as of Sep 15, 2026 · Form 4
24 months: $158K sold

Transaction history

All 13 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

Date	Company	Type	Shares	Price	Value	Owned after	Filing
Sep 15, 2026	RXRXChief Financial Officer	Shares withheld for tax or exercise priceCode F · direct	5,396	$3.41	$18K@ $3.41	1,071,462	Form 4
Aug 17, 2026	RXRXChief Financial Officer	Shares withheld for tax or exercise priceCode F · direct	25,018	$3.16	$79K@ $3.16	1,076,858	Form 4
Jun 15, 2026	RXRXChief Financial Officer	Shares withheld for tax or exercise priceCode F · direct	5,396	$3.15	$17K@ $3.15	1,101,876	Form 4
May 15, 2026	RXRXChief Financial Officer	Shares withheld for tax or exercise priceCode F · direct	25,018	$3.04	$76K@ $3.04	1,107,272	Form 4
Apr 6, 2026	RXRXChief Financial Officer	Shares withheld for tax or exercise priceCode F · direct	48,028	$3.11	$149K@ $3.11	1,132,290	Form 4
Mar 17, 2026	RXRXChief Financial Officer	Open-market saleCode S · direct	7,956	$3.39	$27K@ $3.39	1,180,318	Form 4
Mar 16, 2026	RXRXChief Financial Officer	Shares withheld for tax or exercise priceCode F · direct	7,075	$3.42	$24K@ $3.42	1,188,274	Form 4
Feb 18, 2026	RXRXChief Financial Officer	Open-market saleCode S · direct	13,426	$3.08	$41K@ $3.08	1,195,349	Form 4
Feb 17, 2026	RXRXChief Financial Officer	Shares withheld for tax or exercise priceCode F · direct	11,908	$3.49	$42K@ $3.49	1,208,775	Form 4
Feb 6, 2026	RXRXChief Financial Officer	Shares withheld for tax or exercise priceCode F · direct	11,400	$3.98	$45K@ $3.98	1,220,683	Form 4
Feb 6, 2026	RXRXChief Financial Officer	Grant or awardCode A · direct	24,254	—	—	1,232,083	Form 4
Feb 6, 2026	RXRXChief Financial Officer	Grant or awardCode A · direct	446,279	—	—	1,207,829	Form 4
Dec 29, 2025	RXRXChief Financial Officer	Open-market saleCode S · direct	21,383	$4.18	$89K@ $4.18	761,550	Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.